LES THROMBOPÉNIES INDUITES PAR L'HÉPARINE (TIH) = HEPARIN-INDUCED THROMBOCYTOPENIABACCUS, Ch; HANS, P; BRICHANT, J. F et al.RMLG. Revue médicale de Liège. 2009, Vol 64, Num 9, issn 0370-629X, 450-456 [7 p.]Article

Thrombopénies sous héparinothérapie. Utilisation du danaparoïde (Orgaran®), treize cas monocentriques sous le régime de l'ATU = Thrombocytopenia during heparin therapy. Use of danaparoid (Orgaran®) : about thirteen monocentric cases under the regulation of temporary authorization for prescribing medicineGINDRE, I; DE MAISTRE, E; PERRIN, A et al.Thérapie (Paris). 1997, Vol 52, Num 6, pp 591-597, issn 0040-5957Article

Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulationZMUDA, K; NEOFOTISTOS, D; TS'AO, C.-H et al.American journal of clinical pathology. 2000, Vol 113, Num 5, pp 725-731, issn 0002-9173Article

Danaparoïde et thrombopénie de type II due à l'héparine = Danaparoide and heparin induced thrombocytopenia IILa Revue Prescrire. 2000, Vol 20, Num 208, issn 0247-7750, p. 512Article

Thrombopénies et thromboses induites par l'héparine : Physiopathologie, diagnostic et traitement = Heparin-induced thrombocytopenia: Pathogenesis, diagnosis and treatmentGRUEL, Y.La Revue de médecine interne (Paris). 2004, Vol 25, Num 1, pp 35-45, issn 0248-8663, 11 p.Article

Thrombopénie croisée aux héparines et au danaparoïde = Danaparoide and heparin-induced thrombocytopaeniaGODET, G; BERTRAND, M; VAN DE STEEN, E et al.Annales françaises d'anesthésie et de réanimation. 2001, Vol 20, Num 1, pp 50-53, issn 0750-7658Article

Thrombopénies induites par les héparines : physiopathologie, manifestations biocliniques, diagnostic et traitement = Heparin-induced thrombocytopenia : physiopathology, diagnosis and treatmentGRUEL, Y; POUPLARD, C.STV. Sang thrombose vaisseaux. 1999, Vol 11, Num 6, pp 439-447, issn 0999-7385Article

Heparin-induzierte Thrombozytopenie Typ II im Rahmen einer Hochdosis-Chemotherapie mit anschliessender Stammzellrescue = Heparin-associated thrombocytopenia (HAT II) in a patient undergoing high dose chemotherapy with consecutive stem cell-rescueSAUER, M; GRUHN, B; FUCHS, D et al.Klinische Pädiatrie. 1998, Vol 210, Num 3, pp 102-105, issn 0300-8630Article

Heparin versus danaparoid in off-pump coronary bypass grafting: Results of a prospective randomized clinical trialCARRIER, Michel; ROBITAILLE, Danielle; PERRAULT, Louis P et al.Journal of thoracic and cardiovascular surgery. 2003, Vol 125, Num 2, pp 325-329, issn 0022-5223, 5 p.Article

Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycansSCHICK, Barbara P; GRADOWSKI, Joel F; SAN ANTONIO, James D et al.Thrombosis and haemostasis. 2001, Vol 85, Num 3, pp 482-487, issn 0340-6245Article

Pediatric heparin-induced thrombocytopenia : Management with Danaparoid (orgaran)SAXON, B. R; BLACK, M. D; EDGELL, D et al.The Annals of thoracic surgery. 1999, Vol 68, Num 3, pp 1076-1078, issn 0003-4975Article

Treatment of heparin-induced thrombocytopeniaGREINACHER, A.Thrombosis and haemostasis. 1999, Vol 82, Num 2, pp 457-467, issn 0340-6245Article

College of American Pathologists Conference XXXI on Laboratory Monitoring of Anticoagulant Therapy : The clinical use and Laboratory Monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban : Laboratory monitoring of anticoagulant therapyLAPOSATA, M; GREEN, D; VAN COTT, E. M et al.Archives of pathology & laboratory medicine (1976). 1998, Vol 122, Num 9, pp 799-807, issn 0363-0153Conference Paper

Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid : A prospective studyGRASSEGGER, Alfred; FRITSCH, Peter; REIDER, Norbert et al.Dermatologic surgery. 2001, Vol 27, Num 1, pp 47-52, issn 1076-0512Article

Hémostase. La lépirudine et le danaparoïde, deux nouveaux médicaments très utiles en cas de thrombopénie à l'héparine = Hemostasis. Management of heparin induced thrombocytopenla with danaparoid and lepirudinRIGHINI, M; DE MOERLOOSE, Ph.Médecine et hygiène. 2001, Vol 59, Num 2329, pp 28-30, issn 0025-6749Article

Utilisation de l'Orgaran, héparinoïde de synthèse, lors de deux circulations extracorporelles, chez un même patient allergique à l'héparine = Using a synthetic heparinoid, danaparoid (Orgaran), in two cardiopulmonary bypass procedures in a same patient with heparin-induced thrombocytopeniaPINEAU, E; LE BRET, E; FOLLIGUET, T et al.Archives des maladies du coeur et des vaisseaux. 2001, Vol 94, Num 2, pp 144-147, issn 0003-9683Article

Thrombopénie induite par l'héparine = Heparin-induced thrombocytopeniaDE MAISTRE, E; WAHL, D; BRIQUEL, M. E et al.Annales de cardiologie et d'angéiologie (Paris). 1999, Vol 48, Num 1, pp 37-41, issn 0003-3928Article

Diagnostic et gestion des thrombopénies induites par l'héparine : Aspects biologiques et cliniques = Management of heparin induced thrombopeniaELALAMY, I; PAGE, Y; VIALLON, A et al.Revue des maladies respiratoires. 1999, Vol 16, Num 5BIS, pp 961-974, issn 0761-8425Article

The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controlsBURGESS, J. K; CHONG, B. H.European journal of haematology. 1997, Vol 58, Num 4, pp 279-285, issn 0902-4441Article

Danaparoid (Orgaran) zur Antikoagulation bei der maschinellen Autotransfusion mit Cell Saver 5 (Haemonetics) = Danaparoid (Orgaran) as anticoagulant for autotransfusion with Cell Saver 5 (Haemonetics)VON LÜPKE, U; MARX, A; TESSMANN, R et al.Der Anaesthesist (Berlin. Print). 2001, Vol 50, Num 1, pp 26-31, issn 0003-2417Article

Danaparoid sodium (Orgaran®) in four children with heparin-induced thrombocytopenia type IIZÖHRER, B; ZENZ, W; RETTENBACHER, A et al.Acta paediatrica (Oslo). 2001, Vol 90, Num 7, pp 765-771, issn 0803-5253Article

Failure of danaparoid anticoagulation for cardiopulmonary bypassARIANO, R. E; BHATTACHARYA, S. K; MOON, M et al.Journal of thoracic and cardiovascular surgery. 2000, Vol 119, Num 1, pp 167-168, issn 0022-5223Article

Coagulation complicating cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia receiving the heparinoid, danaparoid sodiumGROCOTT, H. P; ROOT, J; BERKOWITZ, S. D et al.Journal of cardiothoracic and vascular anesthesia. 1997, Vol 11, Num 7, pp 875-877, issn 1053-0770Article

Effect of danaparoid sodium on hard exudates in diabetic retinopathyVAN DER PIJL, J. W; VAN DER WOUDE, F. J; SWART, W et al.Lancet (British edition). 1997, Vol 350, Num 9093, pp 1743-1745, issn 0140-6736Article

Extracorporeal Membrane Oxygenation with Danaparoid Sodium After Massive Pulmonary EmbolismBAUER, Christian; VICHOVA, Zuzana; FFRENCH, Patrick et al.Anesthesia and analgesia. 2008, Vol 106, Num 4, pp 1101-1103, issn 0003-2999, 3 p.Article